CareCloud (CareCloud) 3-Year EBITDA Growth Rate : 0.00% (As of Mar. 2024)

View and export this data going back to 2014. Start your Free Trial

What is CareCloud 3-Year EBITDA Growth Rate?

CareCloud's EBITDA per Share for the three months ended in Mar. 2024 was $0.26.

During the past 12 months, CareCloud's average EBITDA Per Share Growth Rate was -240.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of CareCloud was 216.10% per year. The lowest was -24.40% per year. And the median was 83.90% per year.

Competitive Comparison of CareCloud's 3-Year EBITDA Growth Rate

For the Health Information Services subindustry, CareCloud's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

CareCloud's 3-Year EBITDA Growth Rate Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, CareCloud's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where CareCloud's 3-Year EBITDA Growth Rate falls into.

CareCloud 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

CareCloud (NAS:CCLD) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

CareCloud 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of CareCloud's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

CareCloud (CareCloud) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » CareCloud Inc (NAS:CCLD) » Definitions » 3-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

CCLDP.PFD:USA MTB0:Germany MTB:Germany

Address

7 Clyde Road, Somerset, NJ, USA, 08873

Website

https://www.carecloud.com

CareCloud Inc is a healthcare information technology company. It provides a full suite of proprietary cloud-based solutions and related business services. Its Software-as-a-Service platforms include practice management (PM), electronic health record (EHR), business intelligence, telehealth, patient experience management (PXM) solutions, and robotic processing automation (RPA) bots, along with complementary software tools and business services such as revenue cycle management (RCM), premiere healthcare consulting and implementation services, and on-demand workforce staffing capabilities for high-performance medical groups and health systems nationwide. The operating segments of the group are Healthcare IT, which is the key revenue generating segment, and Practice Management.

Executives

Mahmud Ul Haq	director, 10 percent owner, officer: Chief Executive Officer	7 CLYDE ROAD, SOMERSET NJ 08873
Lawrence Steven Sharnak	director	7393, ORANGEWOOD LANE, BOCA RATON FL 33433
Anne Busquet	director	390 PARK AVE 4TH FLR, NEW YORK NY 10022
A Hadi Chaudhry	officer: President	7 CLYDE ROAD, SOMERSET NJ 08873
Nathalie Grey Garcia	officer: General Counsel & Secretary	7 CLYDE ROAD, SOMERSET NJ 08873
Lawrence J. Steenvoorden	officer: Chief Financial Officer	C/O CHEMBIO DIAGNOSTICS, INC., 555 WIRELESS BOULEVARD, HAUPPAUGE NY 11788
Stephen Andrew Snyder	director, officer: President	7 CLYDE ROAD, SOMERSET NJ 08873
Bill Korn	officer: Chief Financial Officer	61 DARREN DRIVE, BASKING RIDGE NJ 07920
John N Daly	director	390 STANWICH ROAD, GREENWICH CT 06830
Kimberly J Grant	officer: General Counsel & Secretary	7 CLYDE ROAD, SOMERSET NJ 08873
Cameron Munter	director	295 WEST ORANGE GROVE AVE, SIERRA MADRE CA 91024
Shruti H Patel	officer: Interim Corporate Secretary	7 CLYDE ROAD, SOMERSET NJ 08873
Amritpal K. Deol	officer: See Remarks	7 CLYDE ROAD, SOMERSET NJ 08873
Norman Roth	officer: See Remarks	7 CLYDE ROAD, SOMERSET NJ 08873
Brendan Patrick Harney	officer: See Remarks	7 CLYDE ROAD, SOMERSET NJ 08873